{'fraction_non_alphanumeric': 0.060674157303370786, 'fraction_numerical': 0.04887640449438202, 'mean_word_length': 4.364457831325301, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Abstract 11657: Cannabis Use is Associated With Abnormal P-wave Axis


 Introduction:
 Cannabis use has been linked to incident ischemic cerebrovascular disease (CVA) and atrial arrhythmias in various case series and population studies.
 
 
 Hypothesis:
 Cannabis is independently associated with abnormal p-wave axis (aPWA), a marker of atrial myopathy.
 
 
 Methods:
 This analysis included 3,600 (age 48.2 ± 5.9 years, 47.6% male, 69.1% whites) participants from the Third National Health and Nutrition Examination Survey. Cannabis use was defined by self-report. aPWA was defined as p-wave axis outside of 0-75 degrees. Multivariable logistic regression was used to examine the association between cannabis use and aPWA. The consistency of this association was tested among subgroups stratified by demographic and comorbid covariates.
 
 
 Results:
 About 24.3% (n = 875) of participants were ever-cannabis users and 20.4% (n = 735) had aPWA. In multivariable and logistic regression analysis, ever- and former cannabis users had increased odds of aPWA compared to never users [OR (95% CI): 1.27 (1.03-1.56) and 1.28 (1.03-1.59), respectively]. Those reporting ≥10 lifetime uses had 40% increased odds of aPWA [OR (95% CI): 1.40 (1.07-1.84)]. This effect was stronger among ever-users with a history of cardiovascular (CV) disease versus those without [OR (95% CI): 4.11, 95% CI: 1.35 - 12.52, interaction p-value 0.03].
 
 
 Conclusion:
 Cannabis use is associated with atrial myopathy reflected as aPWA. This association is stronger among participants with a history of CV disease. These findings underscore a potential mechanism by which cannabis use increases the risk for ischemic CVA/atrial arrhythmias and highlights the need for personalized cannabis risk assessment.
